Every PMCPA ruling since 2005 — searchable and filterable by company, clause, and ABPI Code version.
Case Library Membership
Search free — but unlock advanced filters to find every case involving a specific company or clause.
Already a member? Sign in →
Case Library Membership
inc. VAT
inc. VAT · cancel any time
Secure payment via Stripe
Need access for your team?
Company licences available for compliance teams, medical affairs, and training programmes.
Get a team quote →1,930 cases found
Complaint alleged Bayer’s US advisory board was disguised pre-licence promotion of Eylea 8mg. Panel initially found breaches, but Appeal Board overturned them…
A pharmacist complained about a rep’s claim that NICE said infliximab SC fell under infliximab IV TAG due to cost neutrality. Panel…
Conference Wi‑Fi sponsored by Gilead redirected delegates to a US corporate homepage featuring a press release about lenacapavir for HIV prevention. Panel…
A US-only Apretude in-app advert was briefly visible to UK users after geo-restrictions failed. Panel initially found a Clause 5.1 breach, but…
Organon’s Nexplanon ad on a closed doctors’ network was alleged to omit key contraindications and cancer-risk context. Panel found the ad and…
Four UK Pfizer employees ‘liked’ a third‑party LinkedIn post naming talazoparib. Panel said the likes proactively disseminated POM info to the public:…
PMCPA ruled an AstraZeneca LinkedIn post was promotional for Calquence (CLL) and lacked mandatory digital prescribing/safety information (PI, INN, AE statement, black…
Two Idorsia banner ads for Quviviq used the term “chronic insomnia”. Complaint alleged off-licence promotion vs SmPC. Panel found authoritative definitions aligned…
PMCPA found Roche breached Clause 5.5 because a patient summary of an AMD audit report did not disclose Roche’s funding within the…
Two anonymous complaints challenged EASI-100 data shown at a LEO promotional symposium. A 1-patient discrepancy between slide figures and supporting analysis meant…
PMCPA ruled AstraZeneca breached Clause 5.5 after sponsorship of a severe asthma article was only declared in an acknowledgements section near the…
AbbVie was found in breach of Clause 5.1 after a Venclyxto SPC on EMC showed “Days 1 7” instead of “Days 1-7”…
Complaint alleged a Rosemont LinkedIn post and website content promoted a specific POM to the public and lacked certification. Panel found the…
PMCPA ruled AstraZeneca breached Clause 5.5 after a contracted HCP tweeted #speakupforCOPD without declaring their association. Website disclosure was deemed sufficiently prominent;…
Complaint about a UK speaker’s CLL symposium at EHA 2023 (Frankfurt) where an ALPINE trial slide was not shown live. Panel found…
Our PMCPA rulings expert has knowledge of over 1,900 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.
